For the quarter ending 2026-03-31, GH made $301,665K in revenue. -$112,075K in net income. Net profit margin of -37.15%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenue | 301,665 | 281,266 | 265,196 | 232,088 |
| Cost of revenue | 104,919 | 99,492 | 93,587 | 81,205 |
| Research and development expense | 91,038 | 98,264 | 89,957 | 87,449 |
| Sales and marketing expense | 169,132 | 143,382 | 127,375 | 119,588 |
| General and administrative expense | 57,926 | 60,933 | 53,266 | 50,259 |
| Other operating expense | - | 0 | - | - |
| Total costs and operating expenses | 423,015 | 402,071 | 364,185 | 338,501 |
| Loss from operations | -121,350 | -120,805 | -98,989 | -106,413 |
| Interest income | 11,151 | 10,032 | 7,391 | 7,560 |
| Interest expense | 1,347 | 1,180 | 943 | 983 |
| Other income (expense), net | -157 | -18,268 | -48 | -25 |
| Loss before provision for income taxes | -111,703 | -130,221 | -92,589 | -99,861 |
| Provision for income taxes | 372 | -1,727 | 136 | 38 |
| Net loss | -112,075 | -128,494 | -92,725 | -99,899 |
| Basic EPS | -0.85 | -0.998 | -0.74 | -0.8 |
| Diluted EPS | -0.85 | -0.998 | -0.74 | -0.8 |
| Basic Average Shares | 131,273,000 | 128,704,000 | 124,807,000 | 124,114,000 |
| Diluted Average Shares | 131,273,000 | 128,704,000 | 124,807,000 | 124,114,000 |
Guardant Health, Inc. (GH)
Guardant Health, Inc. (GH)